GSK Plc
NYSE: GSK
$42.56
-$0.99 (-2.3%)
Closing Price on September 17, 2024
GSK Articles
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
Published:
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
Published:
Nvidia has announced it will partner with GlaxoSmithKline to apply its artificial intelligence and supercomputers for the drug and vaccine discovery process.
Published:
GlaxoSmithKline has announced that it is acquiring a 10% stake in the German biopharma firm CureVac.
Published:
There are still a lot of questions for Amarin must figure out before it gets back on track. For investors, the question is whether it is the market recovery that is lifting the stock instead of the...
Published:
Amarin stock was absolutely crushed at the tail end of March, and now the company is dealing with the fallout. Investors will be asking a lot of tough questions. Namely, is Amarin viable going...
Published:
Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on a roller-coaster ride. Is the stock ready to run?
Published:
Thursday's top analyst upgrades, downgrades and initiations included Barrick Gold, BlackRock, Comcast, Microsoft, NextEra Energy, Ping, Shopify, Tesla, 3D Systems and UnitedHealth.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe's, Noble Energy, PayPal, Square, Target and...
Published:
Mylan is scheduled to release its first-quarter financial results before the markets open on Tuesday, and earnings are expected to be lower than a year ago.
Published:
Last Updated:
With low volatility ratings, big dividends and some growth potential, these five stocks are ideal for investors looking for something they can add to their portfolios and forget about.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and...
Published:
Last Updated:
More and more branded drugs seem to be facing generic competition. The impact might not be so positive for Big Pharma giants, but this can be a serious victory for consumers and patients who are in...
Published:
Last Updated:
Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest year-over-year growth.
Published:
Last Updated:
GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will create a premier global consumer health care company combining...
Published:
Last Updated: